SCHEMBL3659889

SCHEMBL3659889

COC(=O)Nc1ccccc1[N+](=O)[O-]

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.65
MEN1 O00255 1/20 0.65
TP53 P04637 1/20 0.57
KCNMA1 Q12791 1/20 0.56
PDK1 Q15118 1/20 0.56
PDK2 Q15119 1/20 0.56
PDK3 Q15120 1/20 0.56
PDK4 Q16654 1/20 0.56
PHGDH O43175 1/20 0.55
RAB9A P51151 3/20 0.54
GAA P10253 1/20 0.54
CYP3A4 P08684 1/20 0.54
CYP2C9 P11712 1/20 0.54
CYP2C19 P33261 1/20 0.54
NPSR1 Q6W5P4 1/20 0.54
ALDH1A1 P00352 3/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
L3MBTL1 Q9Y468 2/20 0.53
HTT P42858 1/20 0.53
NPC1 O15118 3/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28096883 0.85 KMT2A (0.63) KMT2AMEN1TP53KCNMA1PDK1
SCHEMBL6535747 0.84 KMT2A (0.62) KMT2AMEN1TP53KCNMA1PDK1
SCHEMBL1733957 0.84 PDK1 (0.58) KMT2AMEN1TP53KCNMA1PDK1
SCHEMBL29740651 0.82 KMT2A (0.69) KMT2AMEN1TP53KCNMA1PDK1
SCHEMBL733777 0.82 KMT2A (0.69) KMT2AMEN1TP53KCNMA1PDK1
SCHEMBL6857920 0.82 KMT2A (0.73) KMT2AMEN1TP53KCNMA1PDK1
SCHEMBL11332310 0.82 KMT2A (0.73) KMT2AMEN1TP53KCNMA1PDK1
SCHEMBL383044 0.82 PDK1 (0.59) KMT2AMEN1TP53KCNMA1PDK1
SCHEMBL21059154 0.82 KMT2A (0.67) KMT2AMEN1TP53KCNMA1PDK1
SCHEMBL10035817 0.81 KMT2A (0.77) KMT2AMEN1TP53RAB9AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 180 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4699994-A METHYLATING N-PHENYL CARBAMIC ACID ESTER NIPPON KOKAN KABUSHIKI KAISHA (JP) 1987-10-13 US claimed
CN-118355117-A Oligonucleotide compositions and methods thereof 波涛生命科学有限公司 2024-07-16 CN disclosed
CN-111936487-B Compounds for the treatment of kinase dependent disorders 埃克塞里艾克西斯公司 2024-07-09 CN disclosed
CN-111936136-B Novel imidazopyrimidine compounds and uses thereof 儿童医学中心公司 2024-07-05 CN disclosed
CN-112312909-B Compounds for the treatment of kinase dependent disorders 埃克塞里艾克西斯公司 2024-07-02 CN disclosed
CN-113710660-B DOT1L degradation agent and application thereof 达纳-法伯癌症研究公司 2024-07-02 CN disclosed
CN-118139977-A Double-stranded oligonucleotide compositions and methods relating thereto 波涛生命科学有限公司 2024-06-04 CN disclosed
CN-118139629-A Compositions and methods for editing MECP2 transcripts 波涛生命科学有限公司 2024-06-04 CN disclosed
CN-118076584-A Esters of retinoids and bakuchiol and formulations thereof 康纳根有限公司 2024-05-24 CN disclosed
CN-118055926-A ROCK2 inhibitors and uses thereof 哈佛大学的校长及成员们 2024-05-17 CN disclosed
EP-2231590-A1 ANTITUMORAL COMPOUNDS Pharma Mar S.A. (ES) 2010-09-29 EP disclosed
WO-2009080761-A1 ANTITUMORAL COMPOUNDS PHARMA MAR, S.A. (ES) 2009-07-02 WO disclosed
WO-2009080769-A1 ANTITUMORAL COMPOUNDS PHARMA MAR, S.A. (ES) 2009-07-02 WO disclosed
EP-2032551-A1 ANTITUMORAL DIHYDROPYRAN-2-ONE COMPOUNDS PHARMA MAR, S.A. (ES) 2009-03-11 EP disclosed
CN-101346468-A Amine-containing lipids and uses thereof MASSACHUSETTS INST TECHNOLOGY (US) 2009-01-14 CN disclosed
WO-2007144423-A1 ANTITUMORAL DIHYDROPYRAN-2-ONE COMPOUNDS PHARMA MAR, S.A. (ES) 2007-12-21 WO disclosed
CN-101010336-A Peptide antibiotics and process for preparing same BIOSOURCE PHARM INC (US) 2007-08-01 CN disclosed
CN-1247535-A Aminoepoxides from aminoaldehydes and in-situ formed halomethyl organometallic reagent SEARLE & CO (US) 2000-03-15 CN disclosed
US-4699994-A METHYLATING N-PHENYL CARBAMIC ACID ESTER NIPPON KOKAN KABUSHIKI KAISHA (JP) 1987-10-13 US disclosed
EP-0216273-A2 Method of manufacturing diphenylmethane dicarbamic acid esters NIPPON KOKAN KABUSHIKI KAISHA (JP) 1987-04-01 EP disclosed